The 2010 Investment U Conference is underway! And even if you couldn't make it, now you can "bring home" more than 30 breakthrough presentations from the conference... Order the Deluxe MP3/Video Library for $99 to listen and view on your computer, or the Premier CD plus MP3/Video Library for $149 to listen to and view anywhere.
U.S. Consumers Come Out for CARS
by The Investment U Research Team
Christmas can come in July, or at least late July for auto dealers and automakers. The CARS program, better know as cash for clunkers, is doing exceedingly well for the auto industry.
On Friday when we heard the money was running out, we expected new funds to be added – $2 billion dollars later and one Senate vote away we’re about to see just that.
Ford (NYSE: F) – the only automaker that wasn’t bailed out by the government – is already seeing increased sales, and consumers are probably acknowledging that fact by purchasing vehicles from a company they see as stable.
That’s not to say that General Motors, Chrysler and numerous foreign auto companies aren’t enjoying the spoils as well.
While the program’s success can be see as pent up demand, a good economic policy in action, or a way to clean up the environment, it’s well liked and consumers are buying.
And what that really goes to show is that the American consumer – driver of economies around the world, and an economic force to be reckoned with – hasn’t died off or completely changed their spending habits.
The American consumer is just in a period of hibernation, and will return refreshed as the economy slowly turns around, much like it did after the Great Depression. It’s good to know that they do come out for bargain hunting, a fact that few retailers will miss.
Symbols mentioned in this article: F.
- Can The Battered Auto Sector Mount a Real Recovery In 2010?
- Built Ford Tough: Why This Resilient Automaker Is a Good Long-Term Buy
- The Blueprint for the Auto Industry’s Revival: Detroit Needs to Reinvent Its Wheels
|
The Company Set to Dominate a $60 Billion-a-Year Market
$60 billion is spent on cancer treatment in the U.S. - each year. And one company is poised to receive the lion's share of it.
The medical director at the Alta Bates Comprehensive Cancer Center says, "...possibly a third of our cancer patient population will soon be undergoing this [company's] treatment."
Another doctor at the University of Texas MD Anderson Cancer Center says he intends to treat over 1,000 patients a year with this technology.
Here's how you can claim your stake in the company before this cash infusion sends shares soaring.
Comments
**By submitting your comment you agree to adhere to our Comment Policy and Privacy Policy.Check out our selection of daily Investment Research:
 |
 |
Investment U RSS Feed